Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) shares traded up 2% during mid-day trading on Wednesday . The company traded as high as $1.53 and last traded at $1.53. 292,991 shares changed hands during mid-day trading, a decline of 21% from the average session volume of 368,852 shares. The stock had previously closed at $1.50.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group assumed coverage on Fractyl Health in a report on Tuesday, April 15th. They issued a "buy" rating and a $12.00 target price on the stock.
Check Out Our Latest Analysis on GUTS
Fractyl Health Trading Down 0.7%
The business has a fifty day moving average of $1.81 and a 200-day moving average of $1.62. The company has a debt-to-equity ratio of 4.61, a quick ratio of 2.50 and a current ratio of 2.50. The company has a market capitalization of $74.45 million, a P/E ratio of -0.82 and a beta of 1.58.
Fractyl Health (NASDAQ:GUTS - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported ($0.49) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.49). Fractyl Health had a negative return on equity of 228.66% and a negative net margin of 73,864.52%. Analysts anticipate that Fractyl Health, Inc. will post -1.61 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Fractyl Health
Several large investors have recently bought and sold shares of the stock. 683 Capital Management LLC lifted its stake in Fractyl Health by 4.0% during the 4th quarter. 683 Capital Management LLC now owns 650,000 shares of the company's stock valued at $1,339,000 after acquiring an additional 25,000 shares in the last quarter. Woodline Partners LP lifted its stake in Fractyl Health by 47.2% during the 1st quarter. Woodline Partners LP now owns 516,921 shares of the company's stock valued at $615,000 after acquiring an additional 165,786 shares in the last quarter. Geode Capital Management LLC lifted its stake in Fractyl Health by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 513,079 shares of the company's stock valued at $1,057,000 after acquiring an additional 11,603 shares in the last quarter. Silverarc Capital Management LLC lifted its stake in Fractyl Health by 6.2% during the 4th quarter. Silverarc Capital Management LLC now owns 176,922 shares of the company's stock valued at $364,000 after acquiring an additional 10,256 shares in the last quarter. Finally, Blackstone Inc. bought a new position in Fractyl Health during the 4th quarter valued at $212,000.
About Fractyl Health
(
Get Free Report)
Fractyl Health, Inc, a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
Featured Stories
Before you consider Fractyl Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fractyl Health wasn't on the list.
While Fractyl Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
